ORAMED PHARMACEUTICALS INC. Quarterly Depreciation in USD from Q4 2010 to Q1 2024

Taxonomy & unit
us-gaap: USD
Description
The amount of expense recognized in the current period that reflects the allocation of the cost of tangible assets over the assets' useful lives. Includes production and non-production related depreciation.
Summary
Oramed Pharmaceuticals Inc. quarterly/annual Depreciation history and growth rate from Q4 2010 to Q1 2024.
  • Oramed Pharmaceuticals Inc. Depreciation for the quarter ending March 31, 2024 was $56K, a 51.4% increase year-over-year.
  • Oramed Pharmaceuticals Inc. annual Depreciation for 2023 was $196K, a 238% increase from 2022.
  • Oramed Pharmaceuticals Inc. annual Depreciation for 2022 was $58K, a 24.7% decline from 2021.
  • Oramed Pharmaceuticals Inc. annual Depreciation for 2021 was $77K, a 1000% increase from 2020.
Depreciation, Quarterly (USD)
Depreciation, YoY Quarterly Growth (%)
Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q1 2024 $56K +$19K +51.4% Jan 1, 2024 Mar 31, 2024 10-Q 2024-05-09
Q1 2023 $37K +$26K +236% Jan 1, 2023 Mar 31, 2023 10-Q 2024-05-09
Q1 2022 $11K -$17K -60.7% Jan 1, 2022 Mar 31, 2022 10-Q 2023-05-11
Q4 2021 $18K +$11K +157% Sep 1, 2021 Dec 31, 2021 10-K 2023-03-06
Q1 2021 $28K Jan 1, 2021 Mar 31, 2021 10-Q 2022-05-12
Q4 2020 $7K Sep 1, 2020 Dec 31, 2020 10-QT 2022-03-30
Q4 2018 $2K +$1K +100% Sep 1, 2018 Nov 30, 2018 10-Q 2020-01-09
Q4 2017 $1K $0 0% Sep 1, 2017 Nov 30, 2017 10-Q 2019-01-14
Q4 2016 $1K $0 0% Sep 1, 2016 Nov 30, 2016 10-Q 2018-01-11
Q4 2015 $1K Sep 1, 2015 Nov 30, 2015 10-Q 2017-01-11
Q4 2013 $1.87K -$400 -17.6% Sep 1, 2013 Nov 30, 2013 10-Q 2014-01-14
Q4 2012 $2.27K -$3.77K -62.4% Sep 1, 2012 Nov 30, 2012 10-Q 2014-01-14
Q4 2011 $6.04K -$1.41K -18.9% Sep 1, 2011 Nov 30, 2011 10-Q 2012-12-26
Q4 2010 $7.45K Sep 1, 2010 Nov 30, 2010 10-Q 2012-01-12
* An asterisk sign (*) next to the value indicates that the value is likely invalid.